REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/28/2026
Back to search
Official data from USPTO
LEADXPRO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
03/29/2026
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
03/16/2016
Registration date
03/28/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2023
Last transaction
03/29/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
3
Owner type
25
Owner location
Villigen, CH
Examiner
CALLERY, TIMOTHY JOHN
Law office
N30
Mark description
The mark consists of the stylized wording "LEADXPRO" with the "X" being represented by nine shaded squares presented in an "X" shape.
Holders and representatives
Holders
leadXpro AG
leadXpro AG
Representatives
Dyan M. House Baker & McKenzie LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of infectious diseasesoncologic diseasesdiseases of the central nervous system
Class 42
Scientific and technological researchenablement of structure-based drug design by generation of target proteinmolecular structures by X-ray crystallographyelectron microscopyother methods to generate and design new active pharmaceutical ingredientschemical entities and biopharmaceuticalsfor the treatment of diseases; research and molecular design in the field of medical sciences and pharmaceuticals; industrial analysis and research services in the field of medical sciences and pharmaceuticals
Class 44
Medical services
Publications
History of USPTO decisions and trademark events.
33 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/19/2026
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
08/17/2024
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/24/2024
INPC
INVALIDATION PROCESSED
07/24/2024
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
06/22/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/23/2024
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
10/21/2023
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
10/21/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/21/2023
ES75
TEAS SECTION 71 & 15 RECEIVED
03/27/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/28/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/21/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/30/2017
FIMP
FINAL DISPOSITION PROCESSED
06/30/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/28/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
03/28/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/10/2017
PUBO
PUBLISHED FOR OPPOSITION
01/10/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/21/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/01/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/30/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/29/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/29/2016
RFNT
REFUSAL PROCESSED BY IB
07/22/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/07/2016
RFRR
REFUSAL PROCESSED BY MPU
07/07/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/06/2016
CNRT
NON-FINAL ACTION WRITTEN
07/05/2016
DOCK
ASSIGNED TO EXAMINER
06/27/2016
MAFR
APPLICATION FILING RECEIPT MAILED
06/14/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/10/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/09/2016
Continuous trademark protection
Get notified about every new filing that threatens LEADXPRO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.